Prediction of coronary heart disease risk by Framingham and SCORE risk assessments varies by socioeconomic position: Results from a study in British men

European Journal of Preventive Cardiology

Volumn 18, Issue 2, 2011, Pages 186-193

  Ramsay, Sheena E ^a   Morris, Richard W ^a   Whincup, Peter H ^b   Papacosta, A Olia ^a   Thomas, Mary C ^a   Wannamethee, S Goya ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

coronary heart disease; Risk prediction; socioeconomic variations

Indexed keywords

ADULT; ARTICLE; CORONARY RISK; FRAMINGHAM RISK SCORE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SMOKING; SOCIAL CLASS; SOCIAL STATUS;

ADULT; CHI-SQUARE DISTRIBUTION; CORONARY DISEASE; GREAT BRITAIN; HEALTH SURVEYS; HUMANS; MALE; MEN'S HEALTH; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SOCIAL CLASS; TIME FACTORS;

EID: 79959261507     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/1741826710389394     Document Type: Article

References (30)

1. Allender S, Peto V, Scarborough P, Boxer A, Rayner M. Coronary heart disease statistics 2008. London: British Heart Foundation, 2008.
2. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: Part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001; 104: 2746–2753.
3. JBS 2. Joint British Societies’ guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005; 91: v1–v52.
4. Jackson R, Lawes CM, Bennett DA, Milne RJ, Rodgers A. Treatment with drugs to lower blood pressure and blood cholesterol based on an individual’s absolute cardiovascular risk. Lancet 2005; 365: 434–441.
5. Manuel DG, Lim J, Tanuseputro P, Anderson GM, Alter DA, Laupacis A, et al. Revisiting Rose: strategies for reducing coronary heart disease. BMJ 2006; 332: 659–662.
6. Anderson KM, Odell PM, Wilson PWF, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1991; 121: 293–298.
7. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987–1003.
8. Department of Health. National service framework for coronary heart disease. London: Department of Health, 2000.
9. Cooper A, Nherera L, Calvert N, O’Flynn N, Turnbull N, Robson J, et al. Clinical guidelines and evidence review for lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners, 2008.
10. Brindle P, Emberson J, Lampe F, Walker M, Whincup P, Fahey T, et al. Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ 2003; 327: 1267–1267.
11. Hense HW, Schulte H, Lowel H, Assmann G, Keil U. Framingham risk function overestimates risk of coronary heart disease in men and women from Germany – results from the MONICA Augsburg and the PROCAM cohorts. Eur Heart J 2003; 24: 937–945.
12. Menotti A, Puddu PE, Lanti M. Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur Heart J 2000; 21: 365–370.
13. Thomsen TF, McGee D, Davidsen M, Jorgensen T. A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study. Int J Epidemiol 2002; 31: 817–822.
14. Brindle P, McConnachie A, Upton M, Hart CL, Davey Smith G, Watt GCM, The accuracy of the Framingham risk-score in different socioeconomic groups: a prospective study. B J Gen Pract 2005; 55: 838–845.
15. Tunstall-Pedoe H, Woodward M (for the SIGN group on risk estimation). By neglecting deprivation, cardiovascular risk scoring will exacerbate social gradients in disease. Heart 2006; 92: 307–310.
16. Walker M, Whincup PH, Shaper AG. The British Regional Heart Study 1975–2004. Int J Epidemiol 2004; 33: 1185–1192.
17. HM Stationary Office. Classification of Occupations 1970. London: HM Stationary Office, 1970.
18. Shaper AG, Pocock SJ, Walker M, Cohen NM, Wale CJ, Thomson AG. British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. BMJ 1981; 283: 179–186.
19. Bruce NG, Shaper AG, Walker M, Wannamethee G. Observer bias in blood pressure studies. J Hypertens 1988; 6: 375–380.
20. Thelle DS, Shaper AG, Whitehead TP, Bullock DG, Ashby D, Patel I. Blood lipids in middle-aged British men. Br Heart J 1983; 49: 205–213.
21. D’Agostino RB Sr, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001; 286: 180–187.
22. Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27: 157–172.
23. Cook NR, Ridker PM. Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures. Ann Intern Med 2009; 150: 795–802.
24. Macleod J, Metcalfe C, Davey Smith G, Hart C. Does consideration of either psychological or material disadvantage improve coronary risk prediction? Prospective observational study of Scottish men. J Epidemiol Community Health 2007; 61: 833–837.
25. Woodward M, Brindle P, Tunstall-Pedoe H (for the SIGN group on risk estimation). Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart 2007; 93: 172–176.
26. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 2007; 335: 136–136.
27. Morris R, Petersen I, Marston L, Walters K, Carpenter J, Nazareth I. Bespoke cohort studies needed. BMJ 2009; 339: b3512–b3512.
28. Morris RW, Wannamethee G, Lennon LT, Thomas MC, Whincup PH. Do socioeconomic characteristics of neighbourhood of residence independently influence incidence of coronary heart disease and all-cause mortality in older British men? Eur J Cardiovasc Prev Rehabil 2008; 15: 19–25.
29. Boniface DR, Cottee MJ, Neal D, Skinner A. Social and demographic factors predictive of change over seven years in CHD-related behaviours in men aged 18–49 years. Public Health 2001; 115: 246–252.
30. Davis S, Winkleby M, Farquhar J. Increasing disparity in knowledge of cardiovascular-disease risk-factors and risk-reduction strategies by socioeconomic-status – implications for policy-makers. Am J Prev Med 1995; 11: 318–323.